Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

AKRO – Akero Therapeutics Inc

Name : Akero Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
finviz dynamic chart for AKRO
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=AKRO #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=AKRO &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

10.8

Margin Of Safety %

Put/Call OI Ratio

0.62

EPS Next Q Diff

-0.04

EPS Last/This Y

EPS This/Next Y

-0.72

Price

56.26

Target Price

73.2

Analyst Recom

1

Performance Q

28.94

Relative Volume

2.37

Beta

-0.14

Ticker: AKRO




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02AKRO50.720.630.3337605
2025-06-03AKRO51.680.630.3838251
2025-06-04AKRO53.040.630.0538351
2025-06-05AKRO53.950.620.5838731
2025-06-06AKRO54.240.630.0939249
2025-06-09AKRO54.730.640.0339038
2025-06-10AKRO54.570.690.0237416
2025-06-11AKRO52.920.720.0536641
2025-06-12AKRO53.540.720.5036881
2025-06-13AKRO55.480.720.8837109
2025-06-16AKRO55.790.690.8838025
2025-06-17AKRO55.390.731.4037048
2025-06-18AKRO54.990.742.4237170
2025-06-20AKRO54.180.740.2937284
2025-06-23AKRO54.060.570.7022948
2025-06-24AKRO53.980.580.9123206
2025-06-25AKRO55.040.590.4623735
2025-06-26AKRO56.290.620.1423742
2025-06-27AKRO56.230.620.0523869
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02AKRO50.74-6.0-97.7-3.79
2025-06-03AKRO51.61-6.0-95.9-3.79
2025-06-04AKRO53.02-6.0-100.0-3.79
2025-06-05AKRO53.94-6.0-96.0-3.79
2025-06-06AKRO54.26-6.2-90.4-3.78
2025-06-09AKRO54.71-6.2-82.9-3.78
2025-06-10AKRO54.55-6.2-78.5-3.78
2025-06-11AKRO52.95-6.2-68.1-3.78
2025-06-12AKRO53.56-6.2-84.3-3.78
2025-06-13AKRO55.51-6.2-94.5-3.78
2025-06-16AKRO55.78-6.2-80.8-3.78
2025-06-17AKRO55.41-6.2-77.3-3.78
2025-06-18AKRO54.90-6.2-76.1-3.78
2025-06-20AKRO54.20-6.2-74.5-3.78
2025-06-23AKRO54.01-6.2-78.3-3.78
2025-06-24AKRO53.95-6.2-79.1-3.78
2025-06-25AKRO55.04- -88.2-4.64
2025-06-26AKRO56.31- -89.0-4.64
2025-06-27AKRO56.26-3.7-79.5-3.75
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02AKRO-1.7421.838.78
2025-06-03AKRO-1.7421.838.78
2025-06-04AKRO-1.7421.838.78
2025-06-05AKRO-1.3721.838.78
2025-06-06AKRO-1.3721.838.78
2025-06-09AKRO-1.3721.878.78
2025-06-11AKRO-1.8221.879.64
2025-06-12AKRO-1.8221.879.64
2025-06-13AKRO-2.1521.879.64
2025-06-16AKRO-2.1522.239.64
2025-06-17AKRO-2.1622.239.64
2025-06-18AKRO-2.1622.239.64
2025-06-19AKRO-2.1622.239.64
2025-06-20AKRO-2.1422.239.64
2025-06-24AKRO-2.3121.999.64
2025-06-25AKRO-2.3121.999.64
2025-06-26AKRO-2.3121.9910.80
2025-06-27AKRO-2.3121.9910.80
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=AKRO 589 360 ]

Last Quarter Act. EPS

-0.9

Avg. EPS Est. Current Quarter

-0.84

Avg. EPS Est. Next Quarter

-0.94

Insider Transactions

-2.31

Institutional Transactions

21.99

Beta

-0.14

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

19

Growth Score

19

Sentiment Score

80

Actual DrawDown %

3.7

Max Drawdown 5-Year %

-80

Target Price

73.2

P/E

Forward P/E

PEG

P/S

P/B

4.13

P/Free Cash Flow

EPS

-3.75

Average EPS Est. Cur. Y​

-3.75

EPS Next Y. (Est.)

-4.47

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

2.37

Return on Equity vs Sector %

-48.8

Return on Equity vs Industry %

-30.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

-79.5
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=AKRO 589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=AKRO 589 450 ]
Akero Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 69
Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
stock quote shares AKRO – Akero Therapeutics Inc Stock Price stock today
news today AKRO – Akero Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch AKRO – Akero Therapeutics Inc yahoo finance google finance
stock history AKRO – Akero Therapeutics Inc invest stock market
stock prices AKRO premarket after hours
ticker AKRO fair value insiders trading